PROVIDUS

Scientific and technological services; Scientific services and research related to the same; Scientific services and design related to the same; Platform as a service [PAAS] comprising software platforms for the transmission of images, audiovisual content, video content and messages; Scientific research for medical purposes; Research services, design and development of instruments for control and diagnostics; Scientific research; Electronic data storage; Technical writing, namely medical writing services for the development of medical protocols, clinical study reports, researcher pamphlets, safety reports, informed consent forms, meeting summaries, posters, manuscripts, study diagrams, manuals, and literature reviews; Design, implementation and management of clinical and observational study protocols; Statistical analysis and interpretation of scientific data; Electronic storage of files and documents; computer diagnostic services, computer analysis services; providing online non-downloadable software featuring clinical study and clinical trial management system tools via a website; providing online non-downloadable software featuring study management files; programming of software for study management files; electronic storage services for archiving temporary files throughout the clinical study lifecycle; scientific research, namely programming of software for biostatistics, development of protocols for sample size and statistical power calculations, randomization plans, statistical analysis plans; programming of software for validation in a statistical analysis system; providing online non-downloadable software enabling interpretation and reporting of data for clinical trial reports and publications; product development for others; scientific research, namely intermediate analysis for early decision making; providing online non-downloadable software featuring database and data lists ready for a New Drug Application (NDA), regulatory submission-compliant data files, study data tabulation and data on model regulatory submission standards; medical research and development for new products for others in the field of medical surveillance and safety plans, ongoing oversight of patient-level studies and review of safety data, interpretation of study protocol, consultation on potential safety and medical issues and 24/7 medical surveillance coverage; drug development; drug discovery of adverse events from clinical trials, development of safety update reports and other aggregate reports, development of management safety plans and medical surveillance plans; quality testing of clinical trial's documentation, for example, standard operating procedures (sops) and work instructions, internal system reviews, site audits, provider evaluations; Medical research in the following areas: pharmacology namely simulation, dose selection and optimization, biomarker and endpoint selection, study design optimization, population pharmacokinetic and pharmacodynamic modeling, exposure response modeling; Medical research; Information related to scientific and medical research in the area of clinical trials, namely the design of clinical trials and outcome measures for studying human diseases, or studying or testing drugs, devices, or medical treatment methods on humans; Conducting clinical trials for third parties studying human diseases, or studying or testing drugs, devices, or medical treatment methods on humans; Custom computer programming related to the following fields: image training and integration into computer systems of suitability data with interactive response technology (IRT); design and development of computer databases for the collection, storage, management, analysis and validation of data for use in the medical and pharmaceutical fields; electronic storage services for archiving presentations; Providing information on clinical studies via an interactive website

Health data collection and medical record analysis for scientific studies; Monitoring and follow-up of patients enrolled in non-interventional studies; Providing medical information in the context of real-world evidence (RWE) and post-market studies